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INTRODUCTION: 
The earliest developed fast dissolving technology existed 
in the tablet form and the rapid disintegrating properties 
resulted from special process or formulation modifications. 
Fast dissolving films are gain ing popularity as an 
alternative to fast dissolving tablets as they eliminates 
patient’s fear of chocking and overcome patient 
impediments. Fast dissolving films  generally consists of 
plasticized  hydrocolloids or blends which can be laminated 
by using techniques such as hot-melt extrusion and solvent 
casting. Additionally they also provide easy delivery of 
drug under emet ic condition. Mouth dissolving films, are 
the new drug delivery system for delivery of drugs through 
oral cavity and was developed on the basis of technology 
of the transdermal patch. The delivery system consists of a 
very thin oral strip, which when placed on the patient’s 
tongue or any oral mucosal tissue gets instantly wet by 
saliva and rapidly hydrates and adheres onto the site of 
application. Film then rapidly d isintegrates and dissolves 
to release the medication for absorption through 
oromucosal route or with formula modificat ions, will 
maintain the quick-dissolving aspects allow for 
gastrointestinal absorption to be achieved when 
swallowed. In contrast to other existing, rapid dissolving 
dosage forms, which consist of liophylisates, the rapid 
films can be produced with a manufacturing process that is 
competitive with the manufacturing costs of conventional 
tablets.
 1
 Angina pectoris, commonly known as angina, is 
chest pain due to ischemia of the heart muscle; generally  
due to obstruction or spasm of the coronary arteries (the 
heart's blood vessels).
2
 The model drug selected was 
amlodipine besylate. Amlodipine besylate is chemically  
described as 3-Ethyl-5-methyl (±)-2-[(2-aminoethoxy) 
methyl] -4-(2-chlorophenyl)-1, 4-d ihydro -6-methyl-3, 5-
pyridinedicarboxylate, mono benzenesulphonate 
monohydrate.
3
 
Amlodipine is a dihydropyridine calcium antagonist 
(calcium ion antagonist or slow-channel blocker) that 
inhibits the transmembrane influx of calcium ions into 
vascular smooth muscle and cardiac muscle. Experimental 
data suggest that amlodip ine binds to both dihydropyridine 
and non dihydropyridine binding sites. The contractile 
processes of cardiac muscle and vascular smooth muscle 
are dependent upon the movement of extra cellu lar 
calcium ions into these cells through specific ion channels. 
Amlodipine inhibits calcium ion influx across cell 
membranes selectively, with a greater effect on vascular 
smooth muscle cells than on cardiac muscle cells.
4
 
Generally, the following points are considered for patient 
compliance in case of anti-angina patients, a rapid onset of 
action is necessary for immediate pain relief, patient has 
difficulty to swallow tablet or any another dosage form 
during pain, geriatrics has difficulty to swallow the dosage 
form. By considering the above points, patient 
convenience and compliance oriented research has resulted 
in bringing out safer and newer drug delivery systems one 
of such approach is fast dissolving drug delivery system. 
ABSTRACT: 
Fast-dissolving drug-delivery systems were first developed in the late 1970s as an alternative to tablets, capsules, 
and syrups. Fast dissolving oral films (FDOFs) are the most advanced form of oral solid dosage form due to more 
flexibility and comfort. It improve the efficacy of APIs by dissolving within minute in oral cavity after the contact 
with less saliva as compared to fast dissolving tablets, without chewing and no need of water for administration. 
The FDOFs place as an alternative in the market due to the consumer’s preference for a fast dissolving product over 
conventional tablets / capsules. The oral thin-film technology is still in the beginning stages and has bright future 
ahead because it fulfils all the need of patients. Eventually, film formulations having drug/s will be commercially 
launched using the oral film technology. In the present study fast dissolving film of Amlodipine Besylate was 
prepared using sodium alginate as film forming polymer. To decrease the disintegration time of formulations 
sodium starch glycolate was used as disintegrating agent. A full 32 factorial design was applied using concentration 
of polymer and disintegrant as independent variable and disintegration time and % cumulative drug release as 
dependent variable. Response surface curves were plotted. Batch F6 was found to be the optimized batch as its 
disintegration was completed within the minimum time as compared to all other batches. The formulation (F6) was 
also showing sufficient drug release after 6 min. All the nine formulation was showing approximately 70-85% drug 
release after 6 min.  
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Conventional dosage forms for the anti-angina therapy 
includes tablets and injections. Injections provide effective 
rapid relief but, they are very painfu l and very expensive. 
Sodium starch glycolate is widely  used in oral 
pharmaceuticals as a disintegrant in capsule and tablet 
formulat ions. It is commonly used in tablets prepared by 
either direct-compression or wet granulation processes. 
The usual concentration employed in a formulation is 
between 2% and 8%, with the optimum concentration 
about 4%, although in many cases 2% is sufficient.  
Disintegration occurs by rapid uptake of water followed by 
rapid and enormous swelling.
5
 Glycerin is used in a wide 
variety of pharmaceutical formulations including oral, 
ophthalmic, topical, and parenteral preparations. It is also 
frequently used as a plasticizer in film coatings and 
preparation of soft gelatin capsules. 
6
 
MATERIALS AND METHODS:-  
Amlodipine Besylate hydrochloride was obtained as a gift 
sample from   Hilab Chemicals ltd., Goregaon, 
Mumbai(India). Sodium alginate, Sodium Starch Glycolate 
and glycerine were purchased from Hilab Chemicals ltd., 
Goregaon, Mumbai (India). A ll other chemicals and 
reagent were of analytical g rade. 
COMPATIBILITY S TUDIES:- 
Fourier Transform Infrared S pectr oscopy (FT-IR):  
FT-IR spectroscopy was carried out for the following : (a) 
pure drug amlodip ine besylate (b) amlodipine besylate 
with Sodium alginate (c) amlodipine besylate with SSG 
using Perkin Elmer FTIR model 163 by taking KBr d isc.  
Formulation of films:-  
For formulating the film sodium alg inate was dissolved in 
distilled water. Amlodip ine Besylate and sodium starch 
glycolate was added to the polymer solution. When the 
entire solid material was dissolved in the water, required  
amount of plasticizer (glycerol) was added to the solution. 
The solution was then casted on the plastic films and dried 
in oven at 60 0C. Dried films were removed and stored in 
desiccator till further use.
7
 
Table 1: Formulation of fast dissolving film 
Ingredient F1  F2  F3  F4  F5  F6  F7  F8  F9  
Sodium alg inate (%) 1.25 1.25 1.25 1.5 1.5 1.5 1.75 1.75 1.75 
Amlodipine besylate (mg) 10 10 10 10 10 10 10 10 10 
Aspartame 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 
SSG (%) 1.5 2 2.5 1.5 2 2.5 1.5 2 2.5 
Glycerine (%) 20 20 20 20 20 20 20 20 20 
Distilled water (ml) 20 20 20 20 20 20 20 20 20 
 
EVALUATION OF FILMS: 
Thickness:  
All the batches were evaluated for thickness by using 
calibrated Vernier caliper. Three read ings from all the 
batches were taken and mean thickness was evaluated. 
8
 
Folding endurance:  
The folding endurance was measured manually fo r the 
prepared films. A strip of film was cut and repeatedly 
folded at the same place till it broke. The number of times  
the film could be folded at the same place without 
breaking gave the value of fo lding endurance.
9
 
Drug content:  
Drug content of all n ine batches was determined by UV-
Spectrophotometric  method. For this 1x1 cm2 strip from 
the each film was cut and dissolved in 10ml of simulated 
salivary flu id (pH 6.2). The solution was filtered and 
absorbance was recorded at 239 nm. Drug content was 
calculated by using standard curve of drug.
8
 
Uniformity of drug content:  
For determin ing the uniformity of drug content in the film 
at least three strips (1x1 cm2) were cut from different 
section of the film and drug content was calculated for all 
three strips using the same procedure as above. The drug 
content of all three strips was  compared. Same procedure 
was repeated for all the nine batches .
8 
In vi tro disintegration time: 
In vitro disintegration time is determined visually in a 
glass dish of 25ml distilled water with swirling every 10 
sec. The disintegration time is the time when the film starts 
to break or disintegrates.
1
 
In-vi tro dissolution studies:  
Dissolution study was carried out in USP basket type 
apparatus using the stimulated salivary fluid (pH 6.2) as a 
dissolution medium at 50 rotations per minute. 5ml 
aliquots were withdrawn at different time intervals and 
same amount of fresh dissolution medium was added. The 
aliquots were assayed for drug content at 230.5nm 
wavelength using UV-spectrophotometer. The cumulative 
percentage drug release was calculated.
10,11,12 
RES ULT AND DISCUSSION:- 
Fast dissolving films were prepared using sodium alg inate 
as film forming polymer and sodium starch glycolate as 
disintegrating agent. The films were evaluated for various 
properties such as thickness, drug content etc. The result 
showed that all the films have a smooth surface and good 
folding endurance. Drug content of all the films was 
between 4.6 to 5.01mg. The results are shown in table 2. 
The results of weight and drug content uniformity test 
showed that the film was uniform and drug was also 
uniformly distributed in the films. Films were having 
thickness adequate for handling and use. The 
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disintegration time of the films was evaluated using 
simulated salivary fluid (pH 6.2). Two times readings for 
each batch were recorded i.e. t ime at which disintegration 
started and time when the film completely disintegrates. 
The result indicates that disintegration of films in itialized  
in about 30 sec and completes in 142-197 sec. Batch F3 
and F6 disintegrates most rapidly. The results of in-vitro 
dissolution of all batches are shown in figure.1 
Table 2: Evaluation of amlodipine besylate films 
Batch Thickness(mm) Weight(mg) Drug content Disintegration time  
Start   Complete  
F1 0.221 0.05 4.678 32 197 
F2 0.135 0.03 4.923 28 178 
F3 0.204 0.04 4.812 25 142 
F4 0.201 0.03 4.907 35 202 
F5 0.201 0.04 5.012 38 167 
F6 0.125 0.03 4.827 30 142 
F7 0.158 0.04 4.926 39 200 
F8 0.202 0.03 4.995 35 175 
F9 0. 167 0.04 4.988 32 153 
 
 
Figure 1: In-vitro dissolution studies of fast dissolving films 
Table 3: Regression equation for each response variable determined by multiple regression analysis  
S. 
No. 
Independent 
variables 
Regression 
coefficient 
Y1 ( %  cumulative drug  
released after 6 minutes) 
Y2  
(disintegration time) 
1 b0 - 80.1356 32.6667 
2 b1 X1 -6.5667 3.5000 
3 b2 X2 5.4683 -3.1667 
4 b12 X1x2  - - 
5 b1b2 X1x1  - - 
6 b2b2 X2x2  - - 
 
A full 3
2
 factorial design was applied to study the effect of 
independent variables (conc. of sodium alginate and conc. 
of sodium starch glycolate) on the dependent variable 
(disintegration time and % cumulative drug release after 6 
min). Various coefficients have been shown in table3.  
Response surface plots were plotted which are shown in 
figure 2 & figure 3. Response surface plots showed that the 
% cumulat ive drug release after 6 minutes inversely 
proportional to the concentration of sodium alg inate and 
directly proportional to concentration of sodium starch 
glycolate. The disintegration time is inversely proportional 
to concentration of SSG and directly proportional to 
concentration of sodium alginate.  
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Figure 2: Res ponse surface curve for amlodipine 
besylate films after 6  minutes dissolution 
 
Figure 3: Res ponse surface curve for films showing the 
time at which disintegration initialized 
Table 4: Actual  vs. Predicted res ponse of various dependent variables  
S.No. Code %  cumulative drug release after 6 minutes Disintegration time (Sec) 
Actual  Predicted Actual  Predicted 
1 F1 81.45 80.12968 32 32.29165 
2 F2 84.43 82.86383 28 30.7083 
3 F3 90.4 85.59798 25 29.12495 
4 F4 79.2 78.488 35 33.16665 
5 F5 82.19 81.22215 38 31.5833 
6 F6 86.67 83.9563 30 29.99995 
7 F7 65.09 76.84633 39 34.04165 
8 F8 70.31 79.58048 35 32.4583 
9 F9 81.48 82.31463 32 30.87495 
 
CONCLUS ION:  
It was concluded that the fast dissolving strips of amlodipine besylate can be made by solvent casting technique with 
enhanced dissolution rate, taste masking, and hence better patient compliance and effect ive therapy. 
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